Dentures Denture Repair Kit implant supported dentures occlusal splints Sports Mouthguard

Oral Pathology: Premalignant and Malignant Lesions

Oral Pathology: Premalignant and Malignant Lesions

Introduction

Oral pathology is a vital field in dentistry and medicine that studies diseases affecting the oral and maxillofacial region. Among these, premalignant and malignant lesions are of utmost concern due to their potential to transform into or represent oral cancer. Oral cancer accounts for a significant portion of head and neck cancers and has high morbidity and mortality if not diagnosed early.

Premalignant (or potentially malignant) disorders indicate an increased risk of cancer development. Malignant lesions, on the other hand, are established cancers that invade and destroy tissues, with the potential for metastasis. A sound understanding of their pathogenesis, clinical features, diagnosis, and management is crucial for dental professionals, as early recognition can save lives.

Premalignant Lesions and Disorders

The World Health Organization (WHO) uses the term Oral Potentially Malignant Disorders (OPMDs) to encompass lesions and conditions that carry a risk of progressing to oral cancer.

1. Leukoplakia

  • Definition: A white patch or plaque of the oral mucosa that cannot be wiped off and cannot be clinically or pathologically characterised as any other disease.
  • Etiology: Strongly linked to tobacco use (smoking and smokeless), alcohol consumption, chronic trauma, and human papillomavirus (HPV).
  • Clinical types:
    • Homogeneous leukoplakia: Uniformly white, thin, and flat; lower risk of transformation.
    • Non-homogeneous leukoplakia: Speckled, nodular, or verrucous; higher malignant potential.
  • Sites: Lateral tongue, floor of mouth, buccal mucosa, and gingiva.
  • Malignant transformation rate: 3–20% depending on site and clinical type.

2. Erythroplakia

  • Definition: A fiery red patch that cannot be clinically diagnosed as any other disease.
  • Clinical features: Velvety texture, well-demarcated margins.
  • Sites: Floor of mouth, tongue, soft palate.
  • Risk: Extremely high malignant potential (50–90% show dysplasia or carcinoma at diagnosis).

3. Oral Submucous Fibrosis (OSMF)

  • Etiology: Strongly associated with areca nut (betel quid) chewing, prevalent in South Asia.
  • Pathogenesis: Excessive collagen deposition → progressive fibrosis → rigidity and reduced mouth opening.
  • Clinical features: Burning sensation, pale mucosa, stiff buccal mucosa, trismus.
  • Malignant potential: 7–13%.

4. Lichen Planus

  • Etiology: Chronic immune-mediated mucocutaneous disorder.
  • Clinical types in oral cavity: Reticular (lace-like), erosive, plaque-like, atrophic.
  • Risk: Malignant transformation risk ~1–2%, higher in erosive or atrophic forms.

5. Actinic Cheilitis

  • Etiology: Chronic sun exposure damaging the vermillion border of lips (especially lower lip).
  • Clinical features: Dry, scaly, atrophic, with potential ulceration.
  • Risk: Can transform into squamous cell carcinoma.

6. Other OPMDs

  • Oral candidiasis (chronic hyperplastic type)
  • Discoid lupus erythematosus
  • Syphilitic glossitis

Malignant Lesions

1. Oral Squamous Cell Carcinoma (OSCC)

  • Definition: Malignant epithelial tumour arising from the squamous epithelium of the oral mucosa.
  • Epidemiology: Accounts for >90% of oral cancers; common in individuals aged 40–70, more prevalent in men.
  • Risk factors:
    • Tobacco (smoked and smokeless)
    • Alcohol (synergistic with tobacco)
    • HPV infection (particularly oropharyngeal cancers)
    • Chronic irritation (ill-fitting dentures, sharp teeth)
    • Poor oral hygiene
    • Genetic predisposition and immunosuppression
  • Common sites: Lateral tongue, floor of mouth, gingiva, buccal mucosa, palate, lip.
  • Clinical features:
    • Non-healing ulcer with indurated margins
    • Exophytic growth or verrucous lesion
    • Pain, bleeding, dysphagia in advanced stages
    • Fixation and lymph node metastasis
  • Histopathology: Dysplastic epithelial cells invading basement membrane, keratin pearls, and cellular atypia.
  • Spread: Local invasion, lymphatic metastasis (cervical nodes), distant metastasis (lungs, liver, bones).

2. Verrucous Carcinoma

  • A low-grade variant of SCC.
  • Appears as a slow-growing, warty, exophytic lesion.
  • Common in tobacco chewers.
  • Rarely metastasises but can cause extensive local destruction.

3. Minor Salivary Gland Tumours

  • Include mucoepidermoid carcinoma, adenoid cystic carcinoma, and polymorphous low-grade adenocarcinoma.
  • Sites: palate, lips, buccal mucosa.

4. Malignant Melanoma (Oral)

  • Rare but highly aggressive.
  • Appears as pigmented lesions on palate and gingiva.
  • Poor prognosis due to late detection and high metastatic potential.

Pathogenesis of Malignant Transformation

The development of oral cancer is a multistep process involving genetic, molecular, and environmental factors:

  1. Initiation: Mutations in oncogenes, tumour suppressor genes (e.g., p53, Rb).
  2. Promotion: Chronic exposure to carcinogens (tobacco, alcohol, betel quid).
  3. Progression: Dysplasia → carcinoma in situ → invasive carcinoma.
  4. Molecular changes: Alterations in signalling pathways, angiogenesis, and immune evasion.

Diagnosis of Premalignant and Malignant Lesions

  • Clinical examination: Careful inspection and palpation of oral mucosa.
  • Adjunctive techniques:
    • Toluidine blue staining (identifies dysplastic areas).
    • Autofluorescence and chemiluminescence devices.
  • Biopsy: Gold standard for diagnosis. Incisional biopsy for suspicious lesions.
  • Histopathology: Identifies degree of dysplasia, carcinoma in situ, or invasive carcinoma.
  • Imaging (CT, MRI, PET): Determines tumour extent and metastasis.
  • Molecular markers: Ongoing research in early detection.

Management

For Premalignant Lesions

  • Risk factor modification: Stop tobacco, alcohol, areca nut use; encourage sun protection for lips.
  • Medical therapy: Topical/systemic retinoids, corticosteroids (for OSMF or lichen planus).
  • Surgical excision/laser ablation: For high-risk leukoplakia or erythroplakia.
  • Regular follow-up: Essential due to recurrence risk.

For Malignant Lesions

  • Surgery: Primary treatment; wide local excision with clear margins.
  • Neck dissection: If lymph node metastasis is suspected.
  • Radiotherapy: Used in advanced cases or post-surgery adjuvant therapy.
  • Chemotherapy: Cisplatin, 5-fluorouracil, taxanes (often combined with radiotherapy).
  • Targeted therapy & Immunotherapy: EGFR inhibitors (cetuximab) and immune checkpoint inhibitors (nivolumab, pembrolizumab) are newer modalities.
  • Rehabilitation: Prosthodontic rehabilitation, speech therapy, and psychological support.

Prevention and Public Health Perspective

  • Primary prevention: Tobacco and alcohol cessation campaigns, public awareness.
  • Secondary prevention: Screening high-risk populations (tobacco chewers, alcoholics, elderly).
  • Tertiary prevention: Early diagnosis and treatment to reduce morbidity and mortality.
  • Dentist’s role: Regular oral cancer screening at every dental visit.

Prognosis

  • Early-stage oral cancers (stage I/II) have a good prognosis with ~70–80% 5-year survival.
  • Advanced-stage cancers (stage III/IV) have poor prognosis, with survival dropping to ~30–40%.
  • Prognosis depends on site, stage at diagnosis, nodal involvement, and patient’s overall health.

Premalignant and malignant lesions of the oral cavity represent a continuum from potentially reversible precancerous conditions to life-threatening cancers. Leukoplakia, erythroplakia, OSMF, and lichen planus are important OPMDs that must be identified early and monitored. Oral squamous cell carcinoma, the most common malignant lesion, remains a global health challenge, especially in populations with high tobacco and alcohol use.

Solverwp- WordPress Theme and Plugin